Upcoming events – Biolinerx takes on pancreatic cancer and first data for Homology
Biolinerx’s BL-8040 needs to show improved responses in pancreatic cancer while investors will get a first look at Homology's HMI-102, a gene therapy for…
Noxxon nears crucial combo readout
The tiny German biotech needs strong signals to emerge from an approaching read out of its chemokine-targeting lead project.
